Stay updated on CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial

Sign up to get notified when there's something new on the CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A minor page revision was applied, moving from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T01:41:51.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Only a page revision update from v3.4.0 to v3.4.1 is visible; no core content or study data changes were detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T23:06:54.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    UI and metadata elements were updated, including a visible 'Show glossary' label and capitalization adjustments to the QC-related update text. A site revision banner now shows v3.4.0, replacing the previous v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-28T21:32:51.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no substantive changes to study data, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:53:40.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page's Locations section has been expanded to include new sites across the United States and international locations such as Australia and European regions. This broadens the list of enrolling centers and may affect where patients can participate.
    Difference
    2%
    Check dated 2025-12-23T21:32:33.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Publications note updated to state that PubMed entries are automatically filled from PubMed and may or may not pertain to the study, replacing the previous wording. The revision/version tag was updated to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-25T13:47:43.000Z thumbnail image

Stay in the know with updates to CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial page.